Homi Bhabha Cancer Hospital & Research Centre, A Unit of Tata Memorial Centre under Department of Atomic Energy, Government of India, operational since 2014–2015 in temporary make shift cabins, finally has been commissioned and operational.

As we wrap up another remarkable year, my heartfelt gratitude for each of our staff and the collective achievements we've accomplished together. Our annual report serves not just as a reflection of our past endeavors, but also as a guiding force into the future.

The year 2023 has been very challenging and saw a sea of change in the landscape with all the new blocks operational. Several services including out-patient clinics, joint tumor boards, pharmacy, state-of-the-art laboratories—surgical pathology, microbiology, hematopathology, biochemistry, and molecular diagnostics—inpatient facilities (male, female & paediatric general and private wards with 202 bed strength), high dose radio-isotope therapy wards, modular operation theaters (7) with post-operative recovery and Intensive Units, and Radiation block with state-of-the-art Radiology (CT/ MR/ US/ Mammography/ OPG), Nuclear Medicine (PET-CT / SPECT), and Radiation Oncology set-up (2 Truebeams, 1 Bhabhatron, CT Simulator & Cobalt brachytherapy) are fully functional.

With overall commissioning of all the facilities, we now provide affordable, evidence-based, high quality comprehensive services for common cancer screening, evaluation & work-up, treatment, and palliation. Cancer patients from Andhra Pradesh & neighboring states of Orissa, Chhattisgarh, Jharkhand, and Telangana avail the facilities.

As detailed in this report, in 2023, with more than 7,000 new cancer cases registered and more than 4,000 admissions, approximately 1,700 major/supra-major surgeries, 15,000 day care services, and 1,500 radiation therapy treatments including brachytherapy were offered. Approximately 2,000 new patients attended the Preventive Oncology department for cancer screening and more than 8,000 patients availed Palliative care services. Apart from Hospital services, several community-based programs—health education in schools, training programs for health workers, and screening camps for the benefit of society—have been carried out.

Many departments are now working on starting several training programs—both scientific & medical specialities. In 2023, 4 MD (Radiation Oncology) seats were recognized by NMC and the first batch admission successfully completed. We also have seen an increase in the staff working with us in administration (General, Accounts, HRD, Engineering), Nursing, Scientific, and Technical in various departments.

With a regulatory-approved Institutional Ethics Committee and Clinical Research Secretariat, there has been a steady increase in new projects and publications. With near completion of the entire facility, we look forward to further expansion to cater to increasing patient demand, including a patient hostel, Bone Marrow Transplant Unit, and manpower augmentation.

I feel proud, humbled, and extend my heartfelt thanks to every staff member—Medical, Scientific, Nursing, Technical, Administrative, and others—for all their hard work and dedication in shaping up this institution. Finally, I would like to acknowledge and deeply appreciate the efforts of Tata Memorial Centre and the Department of Atomic Energy!